Illumina Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 9/18/2026)
| Balance Sheet | Total Assets | 6,644,000,000.00 | ROE | 40.98 % |
| Balance Sheet | Total Equity | 2,723,000,000.00 | ROA | 12.79 % |
| Cashflow | Capital Expenditures | -148,000,000.00 | P/FCF | 44.95 |
| Cashflow | Free Cash Flow | 931,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 1,079,000,000.00 | P/CF | 38.79 |
| Income | Earnings per Share (diluted) | 5.52 | Div. Yield | – |
| Income | Net Income | 850,000,000.00 | P/E | 49.23 |
| Income | Shares Outstanding | 154,000,000.00 | P/B | 15.37 |
| Income | Total Revenue | 4,343,000,000.00 | P/S | 9.64 |
Ratios calculated on: 10/14/2026
Company Description
Illumina, Inc. (Illumina) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides a line of genetic analysis solutions, with products and services that serve a range of interconnected markets, including sequencing, genotyping, gene expression, and molecular diagnostics. The Company is organized in two business segments: Life Sciences and Diagnostics. Its Life Sciences business unit includes all products and services related to the research market, namely the product lines based on its sequencing, BeadArray, VeraCode, and real-time PCR technologies. Its Diagnostics business unit focuses on molecular diagnostics. Its customers include genomic research centers, academic institutions, government laboratories, and clinical research organizations. In February 2013, it completed the acquisition of Verinata Health, Inc. Effective July 23, 2013, Illumina Inc acquired Advanced Liquid Logic Inc.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.illumina.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more